Cyclacel Pharmaceuticals Convertible Exchangeable Preferred Stock Ex-Dividend Reminder - 10/17/13

On 10/17/13, Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock (CYCCP) will trade ex-dividend, for its quarterly dividend of $0.15, payable on 11/1/13. As a percentage of CYCCP's recent share price of $7.76, this dividend works out to approximately 1.93%, so look for shares of CYCCP to trade 1.93% lower — all else being equal — when CYCCP shares open for trading on 10/17/13. On an annualized basis, the current yield is approximately 7.74%.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

As of last close, CYCCP was trading at a 22.40% discount to its liquidation preference amount. It should be noted that the preferred shares are convertible, with a conversion ratio of 4.2553.The chart below shows the one year performance of CYCCP shares, versus CYCC:

Performance Comparison Chart

Below is a dividend history chart for CYCCP, showing historical dividends prior to the most recent $0.15 on Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock:

CYCCP+Dividend+History+Chart
Three Months Free, a $100 Value, Just Submit Your Top Stock Pick! (Offer ends 11/10/2013)

In Tuesday trading, Cyclacel Pharmaceuticals, Inc's 6% Convertible Exchangeable Preferred Stock ( CYCCP) is currently trading flat on the day, while the common shares ( CYCC) are down about 0.8%.

null

More from Stocks

Coke's a Better Stock to Buy Than Pepsi on Surprising North America Sales
Amazon Crushes Quarterly Earnings Estimates, Raises the Price of Prime

Amazon Crushes Quarterly Earnings Estimates, Raises the Price of Prime

Barbie Flexes Her Muscle in Mattel's Q1 Earnings

Barbie Flexes Her Muscle in Mattel's Q1 Earnings

Amazon Crushes First-Quarter Profit Estimates -- Watch TheStreet's Live Analysis

Amazon Crushes First-Quarter Profit Estimates -- Watch TheStreet's Live Analysis

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb